| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0005 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |